Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 500 of 2529 entries
View as:

Exploring the Profiles of RMS Patients on Ofatumumab or Ocrelizumab in a Real-World Setting in the Gulf

Phase: N/A Priority: Normal
NCT ID: NCT05266469 Org: User:
Start: 07/26/22 End: 11/11/24 Due: 11/11/25

Study Comparing SOM230 Subcutaneously and Sandostatin Subcutaneously in Acromegalic Patients

Phase: N/A Priority: Normal
NCT ID: NCT00088582 Org: User:
Start: 03/31/04 End: - Due: -

Efficacy and Safety of Rivastigmine Transdermal Patch in Patients With Mild to Moderate Alzheimer's Disease

Phase: N/A Priority: Normal
NCT ID: NCT00423085 Org: User:
Start: 01/31/07 End: 04/30/10 Due: 04/30/11

Open-label, Multicenter Study Assessing Preference for Deferasirox Film-coated Tablet Compared to Dispersible Tablet

Phase: N/A Priority: Normal
NCT ID: NCT02993224 Org: User:
Start: 07/27/17 End: 03/11/21 Due: 03/11/22

Safety and Efficacy of LCI699 in Cushing's Disease Patients

Phase: N/A Priority: Normal
NCT ID: NCT01331239 Org: User:
Start: 03/23/11 End: 10/22/19 Due: 10/22/20

Efficacy of Fixed Combination Therapy of Vildagliptin and Metformin Compared to the Individual Monotherapy Components in Drug Naive Patients With Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT00382096 Org: User:
Start: 09/30/06 End: 06/03/08 Due: 06/03/09

Real-World Treatment Patterns and Outcomes Among Patients With Chronic Myeloid Leukemia in Earlier Lines of Therapy

Phase: N/A Priority: Normal
NCT ID: NCT06692803 Org: User:
Start: 05/23/23 End: 11/30/23 Due: 11/30/24

Study to Evaluate the Impact of the "PROactive Telecoaching Program" on Physical Activity in Patients With COPD.

Phase: N/A Priority: Normal
NCT ID: NCT01992081 Org: User:
Start: 05/31/14 End: 06/30/15 Due: 06/30/16

Efficacy and Safety of Mycograb as Adjunctive Therapy for Cryptococcal Meningitis in Patients With AIDS

Phase: N/A Priority: Normal
NCT ID: NCT00324025 Org: User:
Start: 03/31/07 End: 09/30/07 Due: 09/30/08

CCFZ533X2201 - PoC Study in de Novo Renal Transplantation

Phase: N/A Priority: Normal
NCT ID: NCT02217410 Org: User:
Start: 02/05/15 End: 11/29/17 Due: 11/29/18

Efficacy and Safety of Telbivudine 600mg Tablets in Chinese Patients With Chronic Hepatitis B

Phase: N/A Priority: Normal
NCT ID: NCT00781105 Org: User:
Start: 08/01/08 End: 09/16/10 Due: 09/16/11

A Study of MBG453 in Combination With Hypomethylating Agents in Subjects With IPSS-R Intermediate, High or Very High Risk Myelodysplastic Syndrome (MDS).

Phase: N/A Priority: Normal
NCT ID: NCT03946670 Org: User:
Start: 06/04/19 End: 07/15/24 Due: 07/15/25

Efficacy, Safety and Evolution of Cardiovascular Parameters in Renal Transplant Recipients

Phase: N/A Priority: Normal
NCT ID: NCT01114529 Org: User:
Start: 08/09/10 End: 10/30/14 Due: 10/30/15

A Randomized,Double Blind, Placebo Controlled Study to Assess Efficacy,Safety and Tolerability of BGG492 in Migraine Prevention

Phase: N/A Priority: Normal
NCT ID: NCT01617941 Org: User:
Start: 05/31/16 End: 11/30/16 Due: 11/30/17

A Randomized, Multicenter, Open-label, Parallel-group, 12-week Study to Assess the Efficacy and Safety of Switching From Tiotropium to QVA149 (Indacaterol Maleate/Glycopyrronium Bromide) in Symptomatic Mild to Moderate COPD Patients

Phase: N/A Priority: Normal
NCT ID: NCT02566031 Org: User:
Start: 03/23/13 End: 06/04/18 Due: 06/04/19

A Study of the Experimental Drug BKM120 With Paclitaxel in Patients With HER2 Negative, Locally Advanced or Metastatic Breast Cancer, With or Without PI3K Activation

Phase: N/A Priority: Normal
NCT ID: NCT01572727 Org: User:
Start: 08/31/12 End: 06/30/15 Due: 06/30/16

Aldesleukin in Participants With Metastatic Renal Cell Carcinoma or Metastatic Melanoma

Phase: N/A Priority: Normal
NCT ID: NCT00414765 Org: User:
Start: 09/03/08 End: 03/28/10 Due: 03/28/11

A Randomized Phase III Study to Assess the Effect of a Longer Duration of Consolidation Treatment With Nilotinib on TFR in CP CML.

Phase: N/A Priority: Normal
NCT ID: NCT01743989 Org: User:
Start: 04/15/13 End: 07/08/20 Due: 07/08/21

A Phase II Study to Evaluate the Efficacy and Safety of Oral Ceritinib in Patients With ALK-positive NSCLC Metastatic to the Brain and/or to Leptomeninges

Phase: N/A Priority: Normal
NCT ID: NCT02336451 Org: User:
Start: 04/01/15 End: 02/06/19 Due: 02/06/20

A Phase l/ll Study of AMN107 in Adult Patients With Glivec-intolerant CML or Relapsed-refractory Ph+ALL

Phase: N/A Priority: Normal
NCT ID: NCT00384228 Org: User:
Start: 05/31/05 End: - Due: -

Study to Assess Safety, Efficacy, and Cellular Kinetics of YTB323 in Generalized Myasthenia Gravis

Phase: N/A Priority: Normal
NCT ID: NCT06704269 Org: User:
Start: 04/22/25 End: 10/26/29 Due: 10/26/30

Study of Efficacy and Safety of Eltrombopag in Lower-risk MDS Patients With Platelet Transfusion Dependence

Phase: N/A Priority: Normal
NCT ID: NCT04797000 Org: User:
Start: 05/25/21 End: 12/09/26 Due: 12/09/27

Efficacy and Safety of AEB071 Versus Cyclosporine in de Novo Renal Transplant Recipients

Phase: N/A Priority: Normal
NCT ID: NCT00820911 Org: User:
Start: 09/30/08 End: 07/31/12 Due: 07/31/13

Safety and Efficacy of Switching From Aflibercept to Ranibizumab in Patients With nAMD

Phase: N/A Priority: Normal
NCT ID: NCT02161575 Org: User:
Start: 08/28/14 End: 09/14/17 Due: 09/14/18

A Study of Zigakibart in Adults With IgA Nephropathy

Phase: N/A Priority: Normal
NCT ID: NCT05852938 Org: User:
Start: 07/06/23 End: 06/07/28 Due: 06/07/29